+++
title = "Tweets by Eric Topol " 
date = 2021-08-04T14:04:24+00:00
category = "Twitter"
+++
<div class="thread"> 
<div class="thread-content"> 
Link to the preprint

https://t.co/HihmmLKOvn

Extensive PCR testing showed that fully vaccinated people had lower viral loads than un- or partially vaccinated, supporting decreased potential for Delta transmission</div> 
<hr><div class="profile"> 
<a href="https://twitter.com/erictopol/status/1422921366131515398" target="_blank" rel="noreferer">07:04 UCT-7</a> 
</div> 
<div class="content"> 
The most rigorous assessment to date for Delta breakthroughs, w/ random sampling. The previous @PHE_uk estimate for vaccine effectiveness vs Delta was 88% for Pfizer, 60% for AZ. Israel's (Pfizer) was 60%, likely accurate. No wonder why we're seeing the increase in breakthroughs </div> 
<a href="/twitter/erictopol/images/E7857_iVcAAejPH.png"  ><img src="/twitter/erictopol/images/E7857_iVcAAejPH.png" alt="Twitter image" ></img></a></div> 
<div class="thread"> 
<div class="thread-content"> 
The FDA full approval of vaccines in now expected by Labor Day; it took months to get transparency and communication w/ the public

<a href="https://www.washingtonpost.com/health/2021/08/02/coronavirus-vaccines-fda-full-approval-timeline/" target="_blank" rel="noreferer">https://www.washingtonpost.com/health/2021/08/02/c ...</a> 


This Q&amp;A shows the prior lack of understanding of its urgency; also the implications on boosters </div> 
<a href="/twitter/erictopol/images/E78-_N4UYAc1hso.jpg"  ><img src="/twitter/erictopol/images/E78-_N4UYAc1hso.jpg" alt="Twitter image" ></img></a><hr><div class="profile"> 
<a href="https://twitter.com/erictopol/status/1422944272383283203" target="_blank" rel="noreferer">08:35 UCT-7</a> 
</div> 
<div class="content"> 
Labor Day target (more likely end August)

<a href="https://www.nytimes.com/live/2021/08/04/world/covid-delta-variant-vaccine#the-fda-could-grant-full-approval-to-pfizers-vaccine-by-early-september" target="_blank" rel="noreferer">https://www.nytimes.com/live/2021/08/04/world/covi ...</a> 
 by @SharonLNYT @noahweiland 

<a href="https://www.nytimes.com/2021/07/01/opinion/fda-vaccines-full-approval.html" target="_blank" rel="noreferer">https://www.nytimes.com/2021/07/01/opinion/fda-vac ...</a> 
 @nytopinion 

I applaud the transparency, making it #1 priority.

 It's a shame this wasn't the policy months ago, pre-Delta, when it would have had huge impact </div> 
<a href="/twitter/erictopol/images/E79PU2wUUAMZwuV.jpg"  ><img src="/twitter/erictopol/images/E79PU2wUUAMZwuV.jpg" alt="Twitter image" ></img></a><a href="/twitter/erictopol/images/E79PWZdVIAEGXdf.jpg"  ><img src="/twitter/erictopol/images/E79PWZdVIAEGXdf.jpg" alt="Twitter image" ></img></a></div> 
<div class="thread"> 
<div class="thread-content"> 
Summary Delta breakthrough studies, Ct/viral load,  vaccine effectiveness (VE) 

Only 1 large study of Ct/viral load, shows some vaccine reduction 

VE ranges 39-88%; it's likely ‚â§ 60% at best for mRNA

More data needed, but points to need for boosters for at least some people </div> 
<a href="/twitter/erictopol/images/E79d4qJUYAIwtQZ.jpg"  ><img src="/twitter/erictopol/images/E79d4qJUYAIwtQZ.jpg" alt="Twitter image" ></img></a><hr><div class="thread-content"> 
Overall, these findings certainly are concordant w/ increased Delta breakthrough symptomatic infections we're seeing and a major decline in protection (~95% w/ mRNA) compared with previous strains, as reviewed here https://t.co/al1vE7goSn</div> 
<hr><div class="thread-content"> 
Recall that 1-dose mRNA or AZ had little (30%) efficacy (1st study in Table). All of this reflects Delta's immune evasiveness. We're very lucky it's holding up for reduction of hospitalizations/deaths but thisü¶†is far more formidable for both transmission and our immune response</div> 
<hr><div class="profile"> 
<a href="https://twitter.com/erictopol/status/1422992503259549696" target="_blank" rel="noreferer">11:47 UCT-7</a> 
</div> 
<div class="content"> 
Other implications for the VE drop vs infections. 

For awhile we wondered if the mRNA dosing schedule is Israel (3 weeks) vs UK (8-12 weeks) could account for 39-60% vs 88%, respectively. The new UK study doesn't break down vaccine %, but makes this explanation less likely</div> 
</div> 
<div class="thread"> 
<div class="thread-content"> 
There's little good news for the US Delta wave, but we may be seeing the peak case growth rate for the top 2 states, Louisiana and Florida </div> 
<a href="/twitter/erictopol/images/E795ZpGVkAIupGj.jpg"  ><img src="/twitter/erictopol/images/E795ZpGVkAIupGj.jpg" alt="Twitter image" ></img></a><hr><div class="profile"> 
<a href="https://twitter.com/erictopol/status/1422993905495134213" target="_blank" rel="noreferer">11:52 UCT-7</a> 
</div> 
<div class="content"> 
A better way to see the slowing of case growth is via the log plot, and it looks pretty consistent across the top states </div> 
<a href="/twitter/erictopol/images/E799MOGUcAIHX6K.jpg"  ><img src="/twitter/erictopol/images/E799MOGUcAIHX6K.jpg" alt="Twitter image" ></img></a></div> 
<div class="tweet"> 
<div class="profile"> 
<a href="https://twitter.com/erictopol/status/1423028440664403968" target="_blank" rel="noreferer">14:09 UCT-7</a> 
</div> 
<div class="content"> 
In the pandemic, immunocompromised people (~3% of Americans) are not getting adequate recognition for the potential of in-host evolution of the virus (highlighted studies) and the need for far better approaches to protect them <a href="https://www.nejm.org/doi/full/10.1056/NEJMsb2104756?query=featured_home" target="_blank" rel="noreferer">https://www.nejm.org/doi/full/10.1056/NEJMsb210475 ...</a> 
 @NEJM </div> 
<a href="/twitter/erictopol/images/E7-VPMrVcAAvJ40.jpg"  ><img src="/twitter/erictopol/images/E7-VPMrVcAAvJ40.jpg" alt="Twitter image" ></img></a></div> 
<div class="thread"> 
<div class="thread-content"> 
Just published @NEJM

Prevention of Covid for household contacts with exposure via a single subcutaneous injection: results of a randomized trial of combination monoclonal antibodies shows marked benefit

 <a href="http://www.nejm.org/doi/full/10.1056/NEJMoa2109682" target="_blank" rel="noreferer">http://www.nejm.org/doi/full/10.1056/NEJMoa2109682</a> 
 </div> 
<a href="/twitter/erictopol/images/E7-UV4IVgAEYNkV.jpg"  ><img src="/twitter/erictopol/images/E7-UV4IVgAEYNkV.jpg" alt="Twitter image" ></img></a><a href="/twitter/erictopol/images/E7-UXvhUUAM7eGc.jpg"  ><img src="/twitter/erictopol/images/E7-UXvhUUAM7eGc.jpg" alt="Twitter image" ></img></a><hr><div class="thread-content"> 
fixed link

https://t.co/WT8oPg65EH</div> 
<hr><div class="profile"> 
<a href="https://twitter.com/erictopol/status/1423035331327119360" target="_blank" rel="noreferer">14:37 UCT-7</a> 
</div> 
<div class="content"> 
This is a 1st in 2 ways

1. Use of a sub-Q (under the skin) injection rather than an intravenous infusion of the antibodies; the requirement for an IV infusion had led to reduced use for treatment

2. *Preventing* covid after exposure üëç</div> 
</div> 
<div class="tweet"> 
<div class="profile"> 
<a href="https://twitter.com/erictopol/status/1423039487156707331" target="_blank" rel="noreferer">14:53 UCT-7</a> 
</div> 
<div class="content"> 
Notable: several countries with Delta waves had abrupt U-turns that were short-lived or are stuttering

@OurWorldInData </div> 
<a href="/twitter/erictopol/images/E7-mclEVEAAK1jw.jpg"  ><img src="/twitter/erictopol/images/E7-mclEVEAAK1jw.jpg" alt="Twitter image" ></img></a></div> 
<div class="tweet"> 
<div class="profile"> 
<a href="https://twitter.com/erictopol/status/1423051289429086208" target="_blank" rel="noreferer">15:40 UCT-7</a> 
</div> 
<div class="content"> 
During the 3rd wave in the USA, cases got above 300,000 per day and deaths above 4,000.

In the 4th, Delta wave, cases have already reached ~150,000 in a day, with deaths  ~400 (7-day avg)

[and yes, there's a lag; hospitalizations and #LongCovid are a big deal in this wave]</div> 
</div> 
<div class="tweet"> 
<div class="profile"> 
<a href="https://twitter.com/erictopol/status/1423098035408564225" target="_blank" rel="noreferer">18:46 UCT-7</a> 
</div> 
<div class="content"> 
There really are 2 lines, not 1, for the US and Israel 4th wave ascents.

Israel is quickly getting people age &gt;60 with booster shots, 11% in 3 days; it'll be important to watch for impact in the weeks ahead

<a href="https://twitter.com/erlichya/status/1422785542329151490" target="_blank" rel="noreferer">https://twitter.com/erlichya/status/14227855423291 ...</a> 
 </div> 
<a href="/twitter/erictopol/images/E7_bAouVEAI2J0k.jpg"  ><img src="/twitter/erictopol/images/E7_bAouVEAI2J0k.jpg" alt="Twitter image" ></img></a></div> 
<div class="tweet"> 
<div class="profile"> 
<a href="https://twitter.com/erictopol/status/1423117888991367168" target="_blank" rel="noreferer">20:05 UCT-7</a> 
</div> 
<div class="content"> 
The @Newsweek magazine must be getting desperate for sales to go with this cover. Delta is bad enough; there's no clinical evidence that Delta "Plus" or Lambda provide competition with it. Let's not make bad matters worse and beat this *&amp;^%'inü¶† </div> 
<a href="/twitter/erictopol/images/E7_qEZjVgAIcGwC.jpg"  ><img src="/twitter/erictopol/images/E7_qEZjVgAIcGwC.jpg" alt="Twitter image" ></img></a></div> 


